A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer

KIF20A (RAB6KIFL) belongs to the kinesin superfamily of motor proteins, which play critical roles in the trafficking of molecules and organelles during the growth of pancreatic cancer. Immunotherapy using a previously identified epitope peptide for KIF20A is expected to improve clinical outcomes. A...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Suzuki, Nobuaki, Hazama, Shoichi, Ueno, Tomio, Matsui, Hiroto, Shindo, Yoshitaro, Iida, Michihisa, Yoshimura, Kiyoshi, Yoshino, Shigefumi, Takeda, Kazuyoshi, Oka, Masaaki
Materialtyp: Artigo
Språk:Inglês
Publicerad: Lippincott Williams & Wilkins 2014
Ämnen:
Clinical Studies
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3868021/
https://ncbi.nlm.nih.gov/pubmed/24316554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000012
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk